Streetbeat News

TIVC

Tivic Health Systems, Inc.

https://www.tivichealth.com

Industry

Medical - Devices

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Open

3.16

Mkt cap

Volume

48K

High

3.42

P/E Ratio

0.04

52-wk high

31.45

Low

3.05

Div yield

N/A

52-wk low

2.85

The article lists the stocks that have gained and lost in Wednesday's mid-day session. Notable gainers include Novo Integrated Sciences, Akumin, and Green Giant, which reported positive financial results or updates. On the other hand, Sacks Parente Golf, RVL Pharmaceuticals, and Coherent Corp. were among the biggest losers, with factors such as IPO pricing and disappointing financial results contributing to their decline. Tower Semiconductor's shares fell by 8.2% after the company and Intel mutually agreed to terminate their takeover pending regulatory approval.

Portfolio Pulse from Lisa Levin

August 16, 2023 | 5:02 pm

The Nasdaq Composite fell by 90 points, with the Dow and S&P 500 also trading lower. Target Corporation reported better-than-expected Q2 earnings but lowered its profit forecast. Novo Integrated Sciences, DLocal Limited, and Tivic Health Systems saw their shares rise after positive updates. Meanwhile, RVL Pharmaceuticals, Sacks Parente Golf, and Coherent Corp. saw their shares drop.

Portfolio Pulse from Lisa Levin

August 16, 2023 | 4:16 pm

Tivic Health Systems has begun enrollment for its funded study on a non-invasive bioelectronic device approach to vagus nerve stimulation. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2023 | 2:38 pm

In Wednesday's pre-market session, several healthcare stocks saw significant movement. Gainers included Novo Integrated Sciences (NVOS), MSP Recovery (LIFW), Sonnet BioTherapeutics (SONN), Precision BioSciences (DTIL), T2 Biosystems (TTOO), and Tivic Health Systems (TIVC). Losers included Impel Pharmaceuticals (IMPL), RVL Pharmaceuticals (RVLP), G Medical Innovations (GMVD), Oncternal Therapeutics (ONCT), Science 37 Hldgs (SNCE), and Taysha Gene Therapies (TSHA).

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 1:06 pm

Tivic Health has begun enrollment for a study on a novel non-invasive bioelectronic approach to vagus nerve stimulation. The study is funded by Tivic Health itself.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2023 | 1:02 pm

Shares of several companies including Novo Integrated Sciences, EBET, DLocal Limited, Precision BioSciences, T2 Biosystems, STRATA Skin Sciences, The Alkaline Water Company, Lineage Cell Therapeutics, Tivic Health Systems, and Biophytis S.A. are trading higher in pre-market due to various reasons such as better-than-expected financial results, strategic transactions, and strong quarterly results. On the other hand, shares of Sacks Parente Golf, Coherent Corp., Castellum, Greenbrook TMS, Carmell Therapeutics Corporation, SRM Entertainment, SCYNEXIS, Tower Semiconductor, Trevena, and Mercury Systems are trading lower in pre-market due to reasons such as downbeat quarterly results, pricing of IPO, termination of merger deal, and weak forecasts.

Portfolio Pulse from Lisa Levin

August 16, 2023 | 12:19 pm

Tivic Health Systems (NASDAQ:TIVC) reported Q2 losses of $(0.07) per share, beating the analyst consensus estimate of $(0.08) by 12.5%. However, the company's quarterly sales of $161.00K missed the analyst consensus estimate of $630.00K by 74.44%. This represents a 69.51% decrease over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:46 pm

US stocks traded higher with the Dow Jones gaining more than 350 points. Henry Schein Inc reported better-than-expected Q2 earnings but slightly missed sales consensus. Vistagen Therapeutics, Tabula Rasa HealthCare, and Sequans Communications saw their shares rise after positive news. Sage Therapeutics, Tivic Health Systems, and Yellow Corporation saw their shares drop due to negative developments.

Portfolio Pulse from Lisa Levin

August 07, 2023 | 6:30 pm

During Monday's intraday session, several healthcare stocks experienced significant movements. Vistagen Therapeutics, Nektar Therapeutics, Tabula Rasa HealthCare, Poseida Therapeutics, Enveric Biosciences, and Palatin Techs saw their shares rise, with Vistagen Therapeutics leading the gainers with an 871.4% increase. On the other hand, Sage Therapeutics, Tivic Health Systems, Aceragen, Quantum-Si, Infinity Pharmaceuticals, and BIMI Intl Medical saw their shares fall, with Sage Therapeutics leading the losers with a 52.3% decrease.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 5:31 pm

The article lists the stocks that gained and lost the most during Monday's mid-day trading session. Among the gainers were Vistagen Therapeutics, Save Foods, Poseida Therapeutics, and Missfresh Limited, all of which saw significant jumps in their share prices due to various positive developments. On the other hand, Sage Therapeutics, Tivic Health Systems, Yellow Corporation, and Quantum-Si incorporated were among the biggest losers, with their shares tumbling due to negative news such as worse-than-expected results and regulatory setbacks.

Portfolio Pulse from Lisa Levin

August 07, 2023 | 5:28 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.